empty
 
 
rs
Search
Podrška
Trenutno otvaranje računa
Trgovačka platforma
Depozit/Povlačenje
Search
Za početnike Za trgovce Za partnere Idi na pauzu About InstaSpot
rs
#A Nazad na listu instrumenata #ACB

Menjač valuta

AbbVie Inc
249.71 USD
09 Sep 2026 21:59
Promena cene (% chg)
$-0.05
(-0.02%)
Cena prethodnog zatvaranja
Cena prethodnog zatvaranja

Cena zatvaranja prethodnog dana.
$249.56
Otvaranje
Otvaranje

Cena na otvaranju.
$256.24
Dnevni maksimum
Dnevni maksimum

Najviša cena tokom poslednjeg dana trgovine.
$250.79
Dnevni minimum
Dnevni minimum

Najniža cena tokom poslednjeg dana trgovine
$247.36
Maksimum u 52 nedelje
Maksimum u 52 nedelje

Opseg najviših cena u poslednje 52 nedelje
$262.01
Minimum u 52 nedelje
Minimum u 52 nedelje

Opseg najnižinih cena u poslednje 52 nedelje
$247.36
Preuzmi arhivu
Buy
249.92
Sell
249.71
Otvori grafikon za pregled na celom ekranu
Buy
249.92
Sell
249.71
Preuzmi arhivu
Otvori grafikon za pregled na celom ekranu

AbbVie Inc. About company

AbbVie Inc. is an American biopharmaceutical company. It was founded in 2013 after Abbott Laboratories split into two separate companies. In the same year, AbbVie Inc. was listed on the New York Stock Exchange as a separate company under the ABBV ticker.

The company’s mission is to develop and deliver innovative medicines that solve serious health issues. Since its foundation, the company has invested more than $50 billion in the research and development of world-class medicines.

Nowadays, it employs more than 50,000 people worldwide. Its production facilities and research centers are located in 20 countries.

In 2021, the company's total revenue amounted to $56.2 billion. AbbVie's GAAP net profit for the 6 months of 2022 totaled $5.42 billion, an increase of 25.4% compared to $4.32 billion in the previous year. Its revenue jumped by 4.3% to $28.12 billion against $26.97 billion a year earlier.

AbbVie Inc. shares and factors impacting their price

Currently, the company's shares are traded between $140-145, which is four times higher since its IPO 10 years ago. Over the past year, the stock price has fluctuated in the range of $106.86 -$175.91.

Its shares are growing slowly but surely without sharp price swings. Thus, the purchase of AbbVie Inc. stock can be deemed a good long-term investment.

AbbVie allocates 45-50% of available funds annually to pay dividends to its shareholders. The amount of dividends is quite decent. For this reason, the company is classified as a dividend aristocrat.

Ne možete da razgovarate sada?
Postavite pitanje kroz ćaskanje.